In January 2024, a total of $2.2 million was approved for equity-based investments in the following companies: Azome Therapeutics Inc is an early-stage drug discovery company focused on developing selective antagonists of the NLRP3 inflammasome, an inflammatory pathway critical to the development of a wide variety of diseases. Backstitch, Inc....
During the October 2023 Board of Directors meeting, $2.4 million was approved for equity-based investments in the following companies: Æsir Technologies is on a mission to provide Nickel-Zinc (NiZn) batteries and Energy Storage Solutions (ESS) to aerospace, defense, and commercial customers needing power for critical infrastructure such as data centers...
During the July 2023 Board of Directors meeting, $2.4 million was approved for equity-based investments in the following companies: Caeli Vascular, Inc. was founded by a group of physician and medical technology industry experts to effectively address the significant unmet clinical and economic needs associated with the treatment of large volume...
The Missouri Technology Corporation (MTC) will invest more than $2.3 million in seven Missouri-based high-growth potential startups. The investments will be made through MTC’s Innovation, Development, and Entrepreneurial Advancement (IDEA) Fund Co-Investment Program, and will be funded through the U.S. Department of Treasury’s State Small Business Credit Initiative (SSBCI) program. MTC’s...
The Missouri Technology Corporation (MTC) announced today that it will invest more than $2 million in eight high-growth potential startups that are developing technologies and businesses to create high-paying jobs across Missouri. Investments will be made through MTC’s Innovation, Development, and Entrepreneurial Advancement (IDEA) Fund Co-Investment Program, and is the first distribution...
